IRIS-Coroflex NEO Cohort

NCT06177743 · tracked via the Priya Life Science South Korea tracker

Sponsor

Seung-Jung Park

Phase

Observational

Started

2025-01-09

Last updated

2026-06-25

Condition(s) studied

Coronary Artery StenosisCoronary Artery Disease

Investigational drug(s) / intervention(s)

Coroflex ISAR NEO stent

Coroflex ISAR NEO stent: Percutaneous coronary intervention with Coroflex ISAR NEO stent

Study summary

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Eligibility

Sex

ALL

Min age

19 Years

Max age

—

Healthy volunteers

Inclusion Criteria: 1. Patients ≥ 19 years old 2. Patients receiving Coroflex ISAR NEO stents. 3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: 1. Patients with a mixture of other DESs 2. Terminal illness with life expectancy \<1 year. 3. Patients with cardiogenic shock

Primary outcome measure(s)

the composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target- Vessel Revascularization (TVR) — 12 months
the composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target- Vessel Revascularization (TVR) at 12 months post procedure. A composite endpoint is an endpoint that is a combination of multiple clinical endpoints. An event is considered to have occurred if any one of several different events is observed.

Trial sites (11)

Facility	City	Region	Status
Asan Medical Center	Seoul	Songpa-gu	Recruiting
Bucheon Sejong Hospital	Bucheon-si	South Korea	Recruiting
The Catholic Univ. of Korea BUCHEON ST.Mary's hospital	Bucheon-si	South Korea	Recruiting
Veterans Hospital	Daegu	South Korea	Recruiting
Chonnam National University Hospital	Gwangju	South Korea	Not Yet Recruiting
Inje University Ilsan Paik Hospital	Ilsan	South Korea	Not Yet Recruiting
Myongji Hospital	Ilsan	South Korea	Recruiting
Sejong Chungnam National University Hospital	Sejong	South Korea	Recruiting
Seoul National University Boramae Medical Center	Seoul	South Korea	Not Yet Recruiting
The Catholic university of Korea, ST. Vincent's Hospital	Suwon	South Korea	Recruiting
Uijeongbu Eulji Medical Center	Uijeongbu-si	South Korea	Withdrawn

More Seung-Jung Park trials in South Korea

Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice Active, not recruiting

Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease Recruiting

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice Recruiting

Study of the Natural History of FFR Guided Percutaneous Coronary Intervention Recruiting

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry) Recruiting

Other trials for the same condition

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease Active, not recruiting

Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study. Recruiting

Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE) Recruiting

IRIS-Synergy Cohort in the IRIS-DES Registry Active, not recruiting

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06177743 on ClinicalTrials.gov ↗ ← All trials in South Korea